Prognostic value of PAX3/7–FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis
Authors:
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 96 (1) , 46-53
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Incidence and time trends of soft tissue sarcomas in German children 1985–2004 – A report from the population-based German Childhood Cancer RegistryEuropean Journal of Cancer, 2008
- Clinical relevance of molecular genetics to paediatric sarcomasJournal of Clinical Pathology, 2007
- Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology GroupJournal of Clinical Oncology, 2006
- Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89Journal of Clinical Oncology, 2005
- Aggregate data meta‐analysis with time‐to‐event outcomesStatistics in Medicine, 2002
- Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study VJournal of Pediatric Hematology/Oncology, 2001
- Extracting summary statistics to perform meta-analyses of the published literature for survival endpointsStatistics in Medicine, 1998
- The PAX3-FKHR Fusion Protein Created by the t(2;13) Translocation in Alveolar Rhabdomyosarcomas Is A More Potent Transcriptional Activator than PAX3Molecular and Cellular Biology, 1995
- Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993